Pharmaceutical maker GlaxoSmithKline (GSK) is to invest more than £500 million in UK manufacturing following the chancellor’s announcement of tax relief for UK and European patent profits.
If you have already subscribed please login.
If you have any technical issues please email tech support.
GSK, investment, patent box
